Trial intelligence / Profile preview

Phase III trial of diclofenac epolamine patch for acute localized soft tissue injury

CTR20251470Phase 3Active

Sponsor
Tiandao Pharmaceutical
Start
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of diclofenac in soft tissue injury, sprain, muscle strain, bruise, sponsored by Tiandao Pharmaceutical. Started Apr 2025; status: active.

02

Drugs

diclofenac
03

Conditions

soft tissue injurysprainmuscle strainbruise

Beyond the preview

Go deeper on CTR20251470.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20251470.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call